Skip to main content

Advertisement

SpringerLink
Log in

Post-transplant lymphoproliferative disorder following cytomegalovirus reactivation in a lung recipient

  • Case Report
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Post-transplant lymphoproliferative disorder (PTLD) is a life-threatening complication after lung transplantation, for which several risk factors including pretransplant seronegativity for Epstein-Barr virus are known. However, the impact of cytomegalovirus on PTLD remains to be determined. Here, we describe a case of Epstein-Barr virus-associated polymorphic PTLD that developed shortly after treatment for cytomegalovirus reactivation in a lung transplant recipient who was preoperatively seropositive for both cytomegalovirus and Epstein-Barr virus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Walker RC, Paya CV, Marshall WF, Stickler JG, Wiesner RH, Velosa JA, et al. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant 1995;14:214–221.

    CAS  PubMed  Google Scholar 

  2. Levine SM, Angel L, Anzueto A, Susanto I, Peters JI, Sako EY, et al. A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipients. Chest 1999;116:1273–1277.

    Article  CAS  PubMed  Google Scholar 

  3. Verschuuren EA, Stevens SJ, van Imhoff GW, Middeldorp JM, de Boer C, Koeter G, et al. Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication. Transplantation 2002;73:100–104.

    Article  CAS  PubMed  Google Scholar 

  4. Reams BD, McAdams HP, Howell DN, Steele MP, Davis RD, Palmer SM. Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients. Chest 2003;124:1242–1249.

    Article  PubMed  Google Scholar 

  5. Lee P, Minai OA, Mehta AC, DeCamp MM, Murthy S. Pulmonary nodules in lung transplant recipients: etiology and outcome. Chest 2004;125:165–172.

    Article  PubMed  Google Scholar 

  6. Raj R, Frost AE. Lung retransplantation after posttransplantation lymphoproliferative disorder: a single-center experience and review of literature of PTLD in lung transplant recipients. J Heart Lung Transplant 2005;24:671–679.

    Article  PubMed  Google Scholar 

  7. Gascoigne AD, Shenton BK, White MD, Colquhoun IW, Dark JH, Corris PA. The value of plasma-soluble interleukin 2 receptor monitoring in lung transplantation. Transplantation 1993;56:1029–1031.

    CAS  PubMed  Google Scholar 

  8. Paya CV, Fung JJ, Nalesnik MA, Kieff E, Green M, Gores G, et al. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation 1999;68:1517–1525.

    Article  CAS  PubMed  Google Scholar 

  9. Gao SZ, Chaparro SV, Perlroth M, Montoya JG, Miller JL, DiMiceli S, et al. Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University. J Heart Lung Transplant 2003;22:505–514.

    Article  PubMed  Google Scholar 

  10. Walker RC, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, et al. Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis 1995;20:1346–1353.

    CAS  PubMed  Google Scholar 

  11. Manez R, Breinig MC, Linden P, Wilson J, Torre-Cisneros J, Kusne S, et al. Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis 1997;176:1462–1467.

    Article  CAS  PubMed  Google Scholar 

  12. Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990;12(suppl 7):S754–S766.

    PubMed  Google Scholar 

  13. Guppy AE, Rawlings E, Madrigal JA, Amlot PL, Barber LD. A quantitative assay for Epstein-Barr Virus-specifi c immunity shows interferon-gamma producing CD8+ T cells increase during immunosuppression reduction to treat posttransplant lymphoproliferative disease. Transplantation. 2007;84:1534–1539.

    Article  CAS  PubMed  Google Scholar 

  14. Gautam A, Morrissey PE, Brem AS, Fischer SA, Gohh RY, Yango AF, et al. Use of an immune function assay to monitor immunosuppression for treatment of post-transplant lymphoproliferative disorder. Pediatr Transplant 2006;10:613–616.

    Article  PubMed  Google Scholar 

  15. Chen F, Aoyama A, Okamoto T, Takahashi A, Satoda N, Fujinaga T, et al. Viral infection after lung transplantation. Kyobu Geka 2007;60:982–987.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan

    Akihiro Aoyama, Mitsugu Omasa, Nobuyuki Kondo, Fengshi Chen & Hiroshi Date

  2. Department of Organ Preservation Technology, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan

    Fengshi Chen & Toru Bando

Authors
  1. Akihiro Aoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mitsugu Omasa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nobuyuki Kondo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fengshi Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroshi Date
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Toru Bando
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Toru Bando.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aoyama, A., Omasa, M., Kondo, N. et al. Post-transplant lymphoproliferative disorder following cytomegalovirus reactivation in a lung recipient. Gen Thorac Cardiovasc Surg 58, 251–254 (2010). https://doi.org/10.1007/s11748-009-0526-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-009-0526-x

Key words

Search

Navigation